Published in Mol Med on September 01, 1996
Efficient pseudotyping of murine leukemia virus particles with chimeric human foamy virus envelope proteins. J Virol (1997) 1.90
Comparative analysis of genetically modified dendritic cells and tumor cells as therapeutic cancer vaccines. J Exp Med (2000) 1.71
Versatile retrovirus vector systems for regulated gene expression in vitro and in vivo. Mol Med (1997) 1.35
MAGE-3 immunoreactivity in formalin-fixed, paraffin-embedded primary and metastatic melanoma: frequency and distribution. Am J Pathol (1997) 0.98
Limited density of an antigen presented by RMA-S cells requires B7-1/CD28 signaling to enhance T-cell immunity at the effector phase. PLoS One (2014) 0.75
The dendritic cell system and its role in immunogenicity. Annu Rev Immunol (1991) 23.09
A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science (1991) 14.57
Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci U S A (1993) 11.95
Heterologous protection against influenza by injection of DNA encoding a viral protein. Science (1993) 10.14
Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc Natl Acad Sci U S A (1988) 9.35
Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc Natl Acad Sci U S A (1994) 8.92
Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu Rev Immunol (1994) 8.43
B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell (1995) 6.88
Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science (1994) 6.73
The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med (1993) 6.47
Tumor antigens recognized by T lymphocytes. Annu Rev Immunol (1994) 6.16
Normal development and function of CD8+ cells but markedly decreased helper cell activity in mice lacking CD4. Nature (1991) 5.98
Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice. Science (1992) 5.94
Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells. Science (1993) 5.30
Genetic immunization is a simple method for eliciting an immune response. Nature (1992) 5.30
Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J Exp Med (1994) 4.20
CD8 is needed for development of cytotoxic T cells but not helper T cells. Cell (1991) 4.05
Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science (1994) 3.96
Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes. J Exp Med (1994) 3.94
BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity (1995) 3.13
Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics (1994) 2.93
A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J Exp Med (1992) 2.92
Human papillomaviruses. Annu Rev Microbiol (1994) 2.88
A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J Exp Med (1995) 2.88
Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells. Proc Natl Acad Sci U S A (1995) 2.68
Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines. Immunity (1995) 2.63
Retrovirus packaging cells. Hum Gene Ther (1990) 2.45
CD28-B7 interactions in T-cell activation. Curr Opin Immunol (1994) 2.43
In vivo priming of two distinct antitumor effector populations: the role of MHC class I expression. J Exp Med (1994) 2.01
A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Eur J Immunol (1994) 1.83
Identification and intracellular location of MAGE-3 gene product. Cancer Res (1995) 1.77
Tumour antigens. A new look for the 1990s. Nature (1994) 1.56
Identification of MAGE-1 and MAGE-4 proteins in spermatogonia and primary spermatocytes of testis. Cancer Res (1995) 1.51
A reassessment of the role of B7-1 expression in tumor rejection. J Exp Med (1995) 1.44
Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanomas expressing HLA-Cw*1601. Eur J Immunol (1994) 1.24
Mass spectrometric identification of a naturally processed melanoma peptide recognized by CD8+ cytotoxic T lymphocytes. J Exp Med (1995) 1.24
Expression of MAGE genes in transitional-cell carcinomas of the urinary bladder. Int J Cancer (1995) 1.22
Induction of antigen-specific cytolytic T cells in situ in human melanoma by immunization with synthetic peptide-pulsed autologous antigen presenting cells. Proc Natl Acad Sci U S A (1995) 1.20
Dendritic cells are the most efficient in presenting endogenous naturally processed self-epitopes to class II-restricted T cells. J Immunol (1995) 1.19
MAGE-1 gene product is a cytoplasmic protein. Int J Cancer (1994) 1.17
Isolation and characterization of a MAGE gene family in the Xp21.3 region. Proc Natl Acad Sci U S A (1995) 1.13
DNA-based immunization with chimeric vectors for the induction of immune responses against the hepatitis C virus nucleocapsid. J Virol (1995) 1.03
Melanoma patients immunized with melanoma cell vaccine induce antibody responses to recombinant MAGE-1 antigen. J Immunol (1995) 1.02
The tumor protein MAGE-1 is located in the cytosol of human melanoma cells. Biochem Biophys Res Commun (1994) 1.01
The glioblastoma-derived T-cell suppressor factor/transforming growth factor beta 2 inhibits the generation of lymphokine-activated killer (LAK) cells. Int J Cancer (1988) 0.99
Expression of the MAGE gene family in primary and metastatic human breast cancer: implications for tumor antigen-specific immunotherapy. Int J Cancer (1995) 0.95
A carcinoembryonic antigen polynucleotide vaccine has in vivo antitumor activity. Gene Ther (1995) 0.93
Tumor-derived cytokines induce bone marrow suppressor cells that mediate immunosuppression through transforming growth factor beta. Cancer Immunol Immunother (1992) 0.91
Immunization by direct DNA inoculation induces rejection of tumor cell challenge. Hum Gene Ther (1995) 0.86
Generation of specific anti-melanoma reactivity by stimulation of human tumor-infiltrating lymphocytes with MAGE-1 synthetic peptide. Cancer Immunol Immunother (1994) 0.85
Genes coding for tumor rejection antigens: perspectives for specific immunotherapy. Important Adv Oncol (1994) 0.84
Prevalence and significance of HER-2/neu expression in early epithelial ovarian cancer. Cancer (1994) 0.80
Prostatic specific antigen. Adv Clin Chem (1994) 0.79
Immunosuppression derived from human B-lymphoblastoid and melanoma cell lines. Cancer Invest (1992) 0.76
Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell (1983) 25.46
Selection for animal cells that express the Escherichia coli gene coding for xanthine-guanine phosphoribosyltransferase. Proc Natl Acad Sci U S A (1981) 22.21
Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med (1996) 17.51
Expression of a bacterial gene in mammalian cells. Science (1980) 15.46
Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell (1991) 14.23
Construction and applications of a highly transmissible murine retrovirus shuttle vector. Cell (1984) 13.91
Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci U S A (1993) 11.95
Synthesis of rabbit beta-globin in cultured monkey kidney cells following infection with a SV40 beta-globin recombinant genome. Nature (1979) 9.99
Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc Natl Acad Sci U S A (1988) 9.35
A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc Natl Acad Sci U S A (1996) 8.53
Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature (1999) 7.73
PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth. Science (1996) 6.33
Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nat Med (1997) 6.13
Developmental potential and dynamic behavior of hematopoietic stem cells. Cell (1986) 5.98
High-efficiency gene transfer into mammalian cells: generation of helper-free recombinant retrovirus with broad mammalian host range. Proc Natl Acad Sci U S A (1984) 5.89
Demonstration that CFTR is a chloride channel by alteration of its anion selectivity. Science (1991) 5.82
Introduction of new genetic material into pluripotent haematopoietic stem cells of the mouse. Nature (1984) 5.10
Simian virus 40 DNA directs synthesis of authentic viral polypeptides in a linked transcription-translation cell-free system. Proc Natl Acad Sci U S A (1975) 4.98
Expression of human class II major histocompatibility complex antigens using retrovirus vectors. Proc Natl Acad Sci U S A (1987) 4.84
Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. Genes Dev (1994) 4.58
Physiological consequences of loss of plasminogen activator gene function in mice. Nature (1994) 4.40
Chromosomal position or virus mutation permits retrovirus expression in embryonal carcinoma cells. Cell (1986) 4.32
Pre-proparathyroid hormone: a direct translation product of parathyroid messenger RNA. Proc Natl Acad Sci U S A (1974) 3.24
Two dominant-acting selectable markers for gene transfer studies in mammalian cells. Proc Natl Acad Sci U S A (1988) 3.21
Lineage-specific expression of a human beta-globin gene in murine bone marrow transplant recipients reconstituted with retrovirus-transduced stem cells. Nature (1988) 3.18
A chicken-yeast chimeric beta-tubulin protein is incorporated into mouse microtubules in vivo. Cell (1986) 3.00
Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor. Lab Invest (2000) 2.92
N-WASP deficiency reveals distinct pathways for cell surface projections and microbial actin-based motility. Nat Cell Biol (2001) 2.91
Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites. Nature (1998) 2.82
Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer. Proc Natl Acad Sci U S A (2001) 2.81
Recombinant retroviruses encoding simian virus 40 large T antigen and polyomavirus large and middle T antigens. Mol Cell Biol (1986) 2.81
Regulated expression of a complete human beta-globin gene encoded by a transmissible retrovirus vector. Mol Cell Biol (1987) 2.77
Retrovirus-mediated transfer of human adenosine deaminase gene sequences into cells in culture and into murine hematopoietic cells in vivo. Proc Natl Acad Sci U S A (1986) 2.69
Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells. Proc Natl Acad Sci U S A (1995) 2.68
Dispensable sequence motifs in the RAG-1 and RAG-2 genes for plasmid V(D)J recombination. Proc Natl Acad Sci U S A (1993) 2.65
Development of retrovirus vectors useful for expressing genes in cultured murine embryonal cells and hematopoietic cells in vivo. J Virol (1988) 2.55
Negative regulation of human c-fos expression by the retinoblastoma gene product. Nature (1990) 2.50
Pulmonary epithelial cell expression of GM-CSF corrects the alveolar proteinosis in GM-CSF-deficient mice. J Clin Invest (1996) 2.49
Correction of the genetic defect in hepatocytes from the Watanabe heritable hyperlipidemic rabbit. Proc Natl Acad Sci U S A (1988) 2.44
Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma. Proc Natl Acad Sci U S A (1998) 2.29
Repression of the IgH enhancer in teratocarcinoma cells associated with a novel octamer factor. Science (1989) 2.28
Plasminogen activator inhibitor-1 gene-deficient mice. I. Generation by homologous recombination and characterization. J Clin Invest (1993) 2.20
Direct biochemical mapping of eukaryotic viral DNA by means of a linked transcription-translation cell-free system. Proc Natl Acad Sci U S A (1976) 2.17
Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis. J Clin Invest (1993) 2.08
Retrovirus-mediated transduction of adult hepatocytes. Proc Natl Acad Sci U S A (1988) 2.07
Introduction of a selectable gene into different animal tissue by a retrovirus recombinant vector. Proc Natl Acad Sci U S A (1984) 1.80
Comparative analysis of genetically modified dendritic cells and tumor cells as therapeutic cancer vaccines. J Exp Med (2000) 1.71
Hoechst dye efflux reveals a novel CD7(+)CD34(-) lymphoid progenitor in human umbilical cord blood. Blood (2000) 1.70
Lack of toxicity of alpha-sarcoglycan overexpression supports clinical gene transfer trial in LGMD2D. Neurology (2008) 1.63
Bioactivity of autologous irradiated renal cell carcinoma vaccines generated by ex vivo granulocyte-macrophage colony-stimulating factor gene transfer. Cancer Res (1997) 1.58
Implantation of vascular grafts lined with genetically modified endothelial cells. Science (1989) 1.54
Generation and characterization of urokinase receptor-deficient mice. J Clin Invest (1996) 1.54
Expression of human adenosine deaminase in mice reconstituted with retrovirus-transduced hematopoietic stem cells. Proc Natl Acad Sci U S A (1990) 1.49
Surfactant metabolism in transgenic mice after granulocyte macrophage-colony stimulating factor ablation. Am J Physiol (1996) 1.46
Expression of an exogenous growth hormone gene by transplantable human epidermal cells. Science (1987) 1.44
Tissue-specific and ectopic expression of genes introduced into transgenic mice by retroviruses. Science (1986) 1.38
Individual adenovirus type 5 early region 1A gene products elicit distinct alterations of cellular morphology and gene expression. J Virol (1985) 1.38
Generation of a high-titer retroviral vector capable of expressing high levels of the human beta-globin gene. Proc Natl Acad Sci U S A (1995) 1.36
Versatile retrovirus vector systems for regulated gene expression in vitro and in vivo. Mol Med (1997) 1.35
Construction and properties of replication-competent murine retroviral vectors encoding methotrexate resistance. Mol Cell Biol (1989) 1.33
Secretion of human parathyroid hormone from rat pituitary cells infected with a recombinant retrovirus encoding preproparathyroid hormone. Proc Natl Acad Sci U S A (1984) 1.33
Retroviral expression of the human IL-2 gene in a murine T cell line results in cell growth autonomy and tumorigenicity. EMBO J (1987) 1.26
Transfer of functional EGF receptors to an IL3-dependent cell line. J Cell Physiol (1988) 1.26
Protection of bone marrow transplant recipients from lethal doses of methotrexate by the generation of methotrexate-resistant bone marrow. J Exp Med (1987) 1.24
The molecular biology of Gaucher disease and the potential for gene therapy. Cold Spring Harb Symp Quant Biol (1986) 1.22
Efficient and stable expression of recombinant fibronectin polypeptides. Proc Natl Acad Sci U S A (1987) 1.21
Oligomerization-dependent regulation of motility and morphogenesis by the collagen XVIII NC1/endostatin domain. J Cell Biol (2001) 1.20
Bioactive murine and human interleukin-12 fusion proteins which retain antitumor activity in vivo. Nat Biotechnol (1997) 1.19
Expression of HLA-DR antigen in human class II mutant B-cell lines by double infection with retrovirus vectors. Mol Cell Biol (1987) 1.17
Demonstration of a rational strategy for human prostate cancer gene therapy. J Urol (1994) 1.17
Gene transfer as cancer therapy. Adv Immunol (1995) 1.17
Retroviral transfer of a murine cDNA for multidrug resistance confers pleiotropic drug resistance to cells without prior drug selection. Proc Natl Acad Sci U S A (1988) 1.16
Production of spliced DNA copies of the cottontail rabbit papillomavirus genome in a retroviral vector. Ciba Found Symp (1986) 1.14
Characterization of ryudocan glycosaminoglycan acceptor sites. J Biol Chem (1994) 1.13
Increased levels of spliced RNA account for augmented expression from the MFG retroviral vector in hematopoietic cells. Gene Ther (1996) 1.10
Gene therapy of metastatic cancer by in vivo retroviral gene targeting. Nat Genet (1995) 1.09
Temporary amelioration of hyperlipidemia in low density lipoprotein receptor-deficient rabbits transplanted with genetically modified hepatocytes. Proc Natl Acad Sci U S A (1990) 1.09
Genetically modified keratinocytes transplanted to wounds reconstitute the epidermis. Proc Natl Acad Sci U S A (1994) 1.02
Expression of bcl-X(L) restores cell survival, but not proliferation off effector differentiation, in CD28-deficient T lymphocytes. J Exp Med (2000) 1.01
Tissue-specific expression of functionally rearranged lambda 1 Ig gene through a retrovirus vector. Science (1987) 1.00
Pathway-specific regulation of the synthesis of anticoagulantly active heparan sulfate. J Biol Chem (1994) 0.99
Macrophage growth factors introduced into the kidney initiate renal injury. Mol Med (1996) 0.98
Retrovirus-mediated transfer of the human glucocerebrosidase gene to Gaucher fibroblasts. Mol Biol Med (1986) 0.96
Eukaryotic chromosome transfer: linkage of the murine major histocompatibility complex to an inserted dominant selectable marker. Proc Natl Acad Sci U S A (1984) 0.96
Structure and expression of HLA-DQ alpha and -DX alpha genes: interallelic alternate splicing of the HLA-DQ alpha gene and functional splicing of the HLA-DQ alpha gene using a retroviral vector. Immunogenetics (1987) 0.95
Involvement of interleukin-3 in delayed-type hypersensitivity. Blood (1998) 0.95
Metaphase chromosome transfer of introduced selectable markers. J Mol Appl Genet (1984) 0.95
Antisense RNA complementary to 3' coding and noncoding sequences of creatine kinase is a potent inhibitor of translation in vivo. Proc Natl Acad Sci U S A (1989) 0.95
Cancer cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer as vaccines for the treatment of genitourinary malignancies. Cancer Chemother Pharmacol (2000) 0.93
A case report: immune responses and clinical course of the first human use of granulocyte/macrophage-colony-stimulating-factor-transduced autologous melanoma cells for immunotherapy. Cancer Immunol Immunother (1997) 0.92
Targeting avian leukosis virus subgroup A vectors by using a TVA-VEGF bridge protein. J Virol (2001) 0.91
A biochemical and ultrastructural evaluation of the type 2 Gaucher mouse. Mol Chem Neuropathol (1995) 0.90
Activities of granulocyte-macrophage colony-stimulating factor revealed by gene transfer and gene knockout studies. Stem Cells (1994) 0.90
Gene therapy to target dendritic cells from blood to lymph nodes. Gene Ther (2003) 0.90
Restoration of growth potential in paraclones of human keratinocytes by a viral oncogene. Proc Natl Acad Sci U S A (1989) 0.90
Plasmid DNA encapsulation and release from solvent diffusion nanospheres. J Control Release (2001) 0.88
Purification and characterization of retrovirally transduced hematopoietic stem cells. Proc Natl Acad Sci U S A (1992) 0.88